Standard
Blocked muscle fat oxidation during exercise in neutral lipid storage disease. / Laforêt, Pascal; Ørngreen, Mette; Preisler, Nicolai; Andersen, Grete; Vissing, John.
I:
Archives of Neurology, Bind 69, Nr. 4, 2012, s. 530-3.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Laforêt, P, Ørngreen, M, Preisler, N, Andersen, G
& Vissing, J 2012, '
Blocked muscle fat oxidation during exercise in neutral lipid storage disease',
Archives of Neurology, bind 69, nr. 4, s. 530-3.
https://doi.org/10.1001/archneurol.2011.631APA
Laforêt, P., Ørngreen, M., Preisler, N., Andersen, G.
, & Vissing, J. (2012).
Blocked muscle fat oxidation during exercise in neutral lipid storage disease.
Archives of Neurology,
69(4), 530-3.
https://doi.org/10.1001/archneurol.2011.631Vancouver
Laforêt P, Ørngreen M, Preisler N, Andersen G
, Vissing J.
Blocked muscle fat oxidation during exercise in neutral lipid storage disease.
Archives of Neurology. 2012;69(4):530-3.
https://doi.org/10.1001/archneurol.2011.631Author
Laforêt, Pascal ; Ørngreen, Mette ; Preisler, Nicolai ; Andersen, Grete ; Vissing, John. / Blocked muscle fat oxidation during exercise in neutral lipid storage disease. I: Archives of Neurology. 2012 ; Bind 69, Nr. 4. s. 530-3.
Bibtex
@article{584d6cdca2594baa9247ae0f06d6dbb7,
title = "Blocked muscle fat oxidation during exercise in neutral lipid storage disease",
abstract = "To determine whether impaired exercise capacity in neutral lipid storage disease with myopathy is solely caused by muscle weakness or whether a defect in energy metabolism (blocked fat oxidation) may also play a role.",
author = "Pascal Lafor{\^e}t and Mette {\O}rngreen and Nicolai Preisler and Grete Andersen and John Vissing",
year = "2012",
doi = "10.1001/archneurol.2011.631",
language = "English",
volume = "69",
pages = "530--3",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "The JAMA Network",
number = "4",
}
RIS
TY - JOUR
T1 - Blocked muscle fat oxidation during exercise in neutral lipid storage disease
AU - Laforêt, Pascal
AU - Ørngreen, Mette
AU - Preisler, Nicolai
AU - Andersen, Grete
AU - Vissing, John
PY - 2012
Y1 - 2012
N2 - To determine whether impaired exercise capacity in neutral lipid storage disease with myopathy is solely caused by muscle weakness or whether a defect in energy metabolism (blocked fat oxidation) may also play a role.
AB - To determine whether impaired exercise capacity in neutral lipid storage disease with myopathy is solely caused by muscle weakness or whether a defect in energy metabolism (blocked fat oxidation) may also play a role.
U2 - 10.1001/archneurol.2011.631
DO - 10.1001/archneurol.2011.631
M3 - Journal article
C2 - 22491199
VL - 69
SP - 530
EP - 533
JO - JAMA Neurology
JF - JAMA Neurology
SN - 2168-6149
IS - 4
ER -
